Latest News
-
New investment in innovative approach to osteoarthritis treatment
Posted on:
Key research into the treatment of osteoarthritis is set to be strengthened with the Kolling’s Professor David Hunter receiving a large NHMRC investigator grant. The highly competitive grant was awarded to the Florance and Cope Chair of Rheumatology for a five-year project to transform treatment options and delivery of care for osteoarthritis. Professor Hunter welcomed
Category:
-
Research may lead to early warning test for COVID-19
Posted on:
For many people with COVID-19, the first sign they had the virus was a loss in their sense of smell. Now a team from the Kolling Institute and Royal North Shore Hospital will investigate the correlation between the virus and early symptoms. Study lead Associate Professor Rory Clifton-Bligh said a loss of smell has emerged
Category:
-
Co-ordinated COVID-19 Research Response
Posted on:
Kolling Institute researchers are a key part of a new Northern Sydney Local Health District COVID-19 Clinical Research Group. All major specialist disciplines are represented in the group, taking advantage of the breadth of knowledge across the health campus. Kolling researcher Associate Professor Clifton-Bligh said we formed the group because we saw a clear need
Category:
-
Important national COVID-19 study
Posted on:
For many people with heart disease there’s an increased level of anxiety around the implications of COVID-19, but it’s hoped a new study led by Royal North Shore Hospital will guide future treatment and improve health outcomes. Head of cardiology Professor Ravinay Bhindi has launched the AUS-COVID study, which will involve more than 800 patients
Category:
-
Multiple medications cause frailty, but this can be reversed
Posted on:
A world-first study by a team from the Kolling Institute may inform the future use of multiple medications by older people, minimising adverse impacts including frailty. The longitudinal research is the first preclinical study to demonstrate that multiple medications can impair function in old age, and that stopping some can reduce harm. Research lead, Professor
Category:
-
Celebrating 100 years of research excellence
Posted on:
2020 is an important year for the Kolling Institute as it marks the 100 year anniversary of the research organisation. As the longest-running medical research institute in New South Wales, the Kolling has a very rich history. Originally named the Institute of Pathological Research of NSW, the organisation was established in a cottage within the
Category:
-
Valuable biobanking resource improving health outcomes and strengthening research
Posted on:
For nearly three decades, the Kolling Institute Tumour Bank has been quietly and consistently building a large state resource. It was established in 1992 with a small number of endocrine tumours. Today, it also has breast, colorectal and gynaecological tumour collections, as well as neurological and gastrointestinal samples. The significance of the resource has been
Category:
-
New funding to help reduce Australia’s bowel cancer rates
Posted on:
Professor Mark Molloy’s ground-breaking bowel cancer research has received a boost, with the Cancer Council NSW awarding the Kolling Institute researcher a three-year $450,000 grant. Professor Molloy has welcomed the funding, saying bowel cancer claims more lives each year than breast, prostate or skin cancer. “It is now Australia’s second biggest cancer killer, with more
Category:
-
-
International focus on our ovarian cancer research
Posted on:
In an exciting breakthrough, researchers from the Kolling Institute’s Bill Walsh Lab have identified new genes involved in the spread of ovarian cancer. Tragically, it is the deadliest female cancer, claiming more than 900 lives in Australia each year. Most women are diagnosed relatively late, when the cancer has spread, significantly reducing their chances of
Category: